Lobbying Spend
—
Filings
133
Firms Hired
5
Active Period
2017–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Innovation in Pediatric Drugs Act of 2025
2025 · fourth_quarter · Firm: LMH STRATEGIC SOLUTIONS
Drug pricing issues. S.705 - Innovation in Pediatric Drugs Act of 2025. Issues related to the 340(b) program.
Client expense: — · Firm income: $50,000
Matched citations: S.705
Innovation in Pediatric Drugs Act of 2025
2025 · fourth_quarter · Firm: LMH STRATEGIC SOLUTIONS
Drug pricing issues. S.705 - Innovation in Pediatric Drugs Act of 2025. Issues related to the 340(b)program.
Client expense: — · Firm income: $50,000
Matched citations: S.705
Innovation in Pediatric Drugs Act of 2025
2025 · third_quarter · Firm: LMH STRATEGIC SOLUTIONS
Drug pricing issues. S.705 - Innovation in Pediatric Drugs Act of 2025. Issues related to the 340(b)program.
Client expense: — · Firm income: $40,000
Matched citations: S.705
Innovation in Pediatric Drugs Act of 2025
2025 · third_quarter · Firm: LMH STRATEGIC SOLUTIONS
Drug pricing issues. S.705 - Innovation in Pediatric Drugs Act of 2025. Issues related to the 340(b)program.
Client expense: — · Firm income: $40,000
Matched citations: S.705
Innovation in Pediatric Drugs Act of 2025
2025 · second_quarter · Firm: LMH STRATEGIC SOLUTIONS
Drug pricing issues. S.705 - Innovation in Pediatric Drugs Act of 2025. Issues related to the 340(b)program.
Client expense: — · Firm income: $40,000
Matched citations: S.705
Innovation in Pediatric Drugs Act of 2025
2025 · second_quarter · Firm: LMH STRATEGIC SOLUTIONS
Drug pricing issues. S.705 - Innovation in Pediatric Drugs Act of 2025. Issues related to the 340(b)program.
Client expense: — · Firm income: $40,000
Matched citations: S.705
General healthcare issues impacting GSK. S.864 - HELP Copays Act.
Client expense: — · Firm income: $40,000
Matched citations: S.864
General healthcare issues impacting GSK. S.864 - HELP Copays Act.
Client expense: — · Firm income: $40,000
Matched citations: S.864
Lower Costs, More Transparency Act
2024 · fourth_quarter · Firm: LMH STRATEGIC SOLUTIONS
General healthcare issues impacting GSK. H.R.7085 - BIOSECURE Act. H.R.830 - HELP Copays Act. H.R.5378 - Lower Costs, More Transparency Act. S.1542 - DRUG Act.
Client expense: — · Firm income: $40,000
Matched citations: H.R.5378
Lower Costs, More Transparency Act
2024 · fourth_quarter · Firm: LMH STRATEGIC SOLUTIONS
General healthcare issues impacting GSK. H.R.7085 - BIOSECURE Act. H.R.830 - HELP Copays Act. H.R.5378 - Lower Costs, More Transparency Act. S.1542 - DRUG Act.
Client expense: — · Firm income: $40,000
Matched citations: H.R.5378
General healthcare issues impacting GSK. H.R.7085 - BIOSECURE Act. H.R.830 - HELP Copays Act. H.R.5378 - Lower Costs, More Transparency Act. S.1542 - DRUG Act.
Client expense: — · Firm income: $40,000
Matched citations: H.R.7085
General healthcare issues impacting GSK. H.R.7085 - BIOSECURE Act. H.R.830 - HELP Copays Act. H.R.5378 - Lower Costs, More Transparency Act. S.1542 - DRUG Act.
Client expense: — · Firm income: $40,000
Matched citations: H.R.7085
General healthcare issues impacting GSK. H.R.7085 - BIOSECURE Act. H.R.830 - HELP Copays Act. H.R.5378 - Lower Costs, More Transparency Act. S.1542 - DRUG Act.
Client expense: — · Firm income: $40,000
Matched citations: H.R.830
General healthcare issues impacting GSK. H.R.7085 - BIOSECURE Act. H.R.830 - HELP Copays Act. H.R.5378 - Lower Costs, More Transparency Act. S.1542 - DRUG Act.
Client expense: — · Firm income: $40,000
Matched citations: H.R.830
General healthcare issues impacting GSK. H.R.7085 - BIOSECURE Act. H.R.830 - HELP Copays Act. H.R.5378 - Lower Costs, More Transparency Act. S.1542 - DRUG Act.
Client expense: — · Firm income: $40,000
Matched citations: S.1542
General healthcare issues impacting GSK. H.R.7085 - BIOSECURE Act. H.R.830 - HELP Copays Act. H.R.5378 - Lower Costs, More Transparency Act. S.1542 - DRUG Act.
Client expense: — · Firm income: $40,000
Matched citations: S.1542
Lower Costs, More Transparency Act
2024 · third_quarter · Firm: LMH STRATEGIC SOLUTIONS
General healthcare issues impacting GSK. H.R.7085 - BIOSECURE Act. H.R.830 - HELP Copays Act. H.R.5378 - Lower Costs, More Transparency Act. S.1542 - DRUG Act.
Client expense: — · Firm income: $40,000
Matched citations: H.R.5378
Lower Costs, More Transparency Act
2024 · third_quarter · Firm: LMH STRATEGIC SOLUTIONS
General healthcare issues impacting GSK. H.R.7085 - BIOSECURE Act. H.R.830 - HELP Copays Act. H.R.5378 - Lower Costs, More Transparency Act. S.1542 - DRUG Act.
Client expense: — · Firm income: $40,000
Matched citations: H.R.5378
General healthcare issues impacting GSK. H.R.7085 - BIOSECURE Act. H.R.830 - HELP Copays Act. H.R.5378 - Lower Costs, More Transparency Act. S.1542 - DRUG Act.
Client expense: — · Firm income: $40,000
Matched citations: H.R.7085
General healthcare issues impacting GSK. H.R.7085 - BIOSECURE Act. H.R.830 - HELP Copays Act. H.R.5378 - Lower Costs, More Transparency Act. S.1542 - DRUG Act.
Client expense: — · Firm income: $40,000
Matched citations: H.R.7085
General healthcare issues impacting GSK. H.R.7085 - BIOSECURE Act. H.R.830 - HELP Copays Act. H.R.5378 - Lower Costs, More Transparency Act. S.1542 - DRUG Act.
Client expense: — · Firm income: $40,000
Matched citations: H.R.830
General healthcare issues impacting GSK. H.R.7085 - BIOSECURE Act. H.R.830 - HELP Copays Act. H.R.5378 - Lower Costs, More Transparency Act. S.1542 - DRUG Act.
Client expense: — · Firm income: $40,000
Matched citations: H.R.830
General healthcare issues impacting GSK. H.R.7085 - BIOSECURE Act. H.R.830 - HELP Copays Act. H.R.5378 - Lower Costs, More Transparency Act. S.1542 - DRUG Act.
Client expense: — · Firm income: $40,000
Matched citations: S.1542
General healthcare issues impacting GSK. H.R.7085 - BIOSECURE Act. H.R.830 - HELP Copays Act. H.R.5378 - Lower Costs, More Transparency Act. S.1542 - DRUG Act.
Client expense: — · Firm income: $40,000
Matched citations: S.1542
Lower Costs, More Transparency Act
2024 · second_quarter · Firm: LMH STRATEGIC SOLUTIONS
General healthcare issues impacting GSK. H.R.7085 - BIOSECURE Act. H.R.830 - HELP Copays Act. H.R.5378 - Lower Costs, More Transparency Act. S.1542 - DRUG Act.
Client expense: — · Firm income: $40,000
Matched citations: H.R.5378
Source: Senate LDA